BioLife Solutions Inc. vs. CONMED Corporation
BioLife Solutions Inc. (BLFS) comes out ahead, leading on 5 of 9 compared factors.
Size & Scale
| BLFS | CNMD | |
|---|---|---|
| Market Cap | $1.77 billion | $1.38 billion |
| Revenue (TTM) | $102.82 million | $1.37 billion |
| Net Income (TTM) | $57.98 million | $56.50 million |
BLFS leads on 2 of 3 size & scale factors.
Valuation
| BLFS | CNMD | |
|---|---|---|
| P/E Ratio | 30.60 | 24.94 |
| Price / Book | 4.21 | 1.33 |
| Price / Sales | 17.18 | 1.01 |
CNMD leads on 3 of 3 valuation factors.
Profitability
| BLFS | CNMD | |
|---|---|---|
| Net Margin | 56.39% | 4.12% |
| Return on Equity | 13.80% | 5.43% |
BLFS leads on 2 of 2 profitability factors.
Dividend
| BLFS | CNMD | |
|---|---|---|
| Dividend Yield | — | 1.73% |
| Payout Ratio | — | 43.24 |
BLFS and CNMD split the dividend factors evenly.
Risk & Sentiment
| BLFS | CNMD | |
|---|---|---|
| Short Interest | 1.61% | 2.50% |
BLFS leads on 1 of 1 risk & sentiment factors.
Dig deeper: BLFS overview, BLFS financials, CNMD overview, CNMD financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.